GlassScriptPhysician profile
Lubna Bashir Munshi
NPI 1750723433
$1,886.54
in general payments reported to CMS, 2019-2025
20 companies · $541 in 2025
The $541 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $258 · 2022: $133 · 2023: $174 · 2024: $780 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,495.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $832.92 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $139.90 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Kyowa Kirin, INC. | $114.53 | 2025 | |
| Abbvie INC. | $102.12 | 2023-2025 | |
| Alexion Pharmaceuticals, INC. | $84.22 | 2025 | Strensiq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.76 | 2023-2025 | Jardiance |
| Tandem Diabetes Care, INC. | $74.15 | 2023-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Beta Bionics, INC. | $71.85 | 2024 | Ilet Bionic Pancreas |
| Insulet Corporation | $64.56 | 2023-2025 | Omnipod |
| Amphastar Pharmaceuticals, INC. | $53.03 | 2024-2025 | |
| Radius Health, INC. | $49.54 | 2024 | Tymlos |
| Dexcom, INC. | $44.79 | 2024-2025 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $32.42 | 2023-2024 | Gvoke Hypopen, Recorlev |
| Sanofi-Aventis U.S. LLC | $30.36 | 2023-2024 | |
| Corcept Therapeutics | $29.10 | 2024 | Korlym |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $17.68 | 2025 | Unithroid |
| Sequel Med Tech, LLC | $16.83 | 2025 | Twiist |
| Pfizer INC. | $16.80 | 2024 | |
| Lifescan, INC. | $15.86 | 2023 | |
| Medtronic, INC. | $13.12 | 2023 | Minimed 780g |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lubna Munshi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.